Selective estrogen receptor modulators as brain therapeutic agents

Area of Science:

• Neuroscience
• Pharmacology
• Endocrinology

Background:

• Selective estrogen receptor modulators (SERMs) are clinically used for breast cancer, osteoporosis, and menopausal symptoms.
• SERMs exert effects beyond reproductive tissues, including the central nervous system.
• Emerging evidence suggests SERMs possess neuroprotective properties.

Purpose of the Study:

• To review the neurobiological effects of SERMs.
• To explore the potential of SERMs in treating neurological and psychiatric disorders.
• To highlight the therapeutic promise of novel SERMs for brain health.

Main Methods:

• Literature review of preclinical and clinical studies on SERMs and the nervous system.
• Analysis of experimental models for neural trauma, neuroinflammation, neurodegeneration, cognitive impairment, and affective disorders.
• Examination of the molecular mechanisms underlying SERM neuroprotection.

Main Results:

• Certain SERMs demonstrate neuroprotective effects across diverse experimental models.
• SERMs have shown efficacy in reducing neural damage and improving outcomes in models of brain injury and disease.
• Specific SERMs modulate neuronal and glial cell functions.

Conclusions:

• SERMs represent a class of drugs with significant potential for treating a range of brain disorders.
• Targeting specific neuronal and glial pathways with novel SERMs could lead to innovative therapeutic strategies.
• Further research into SERM neurobiology is warranted to optimize their clinical application in neurology and psychiatry.